News - Page 90 - Psychedelic Alpha

Introducing The Psychedelic Practitioner, a new publication by Psychedelic Alpha.

Read more about the article Algernon Pharmaceuticals Receives Approval for Groundbreaking Phase 1 DMT Human Stroke Study

Algernon Pharmaceuticals Receives Approval for Groundbreaking Phase 1 DMT Human Stroke Study

Post published:September 13, 2022
Post category:Press Release

Read more about the article Psychedelic Bulletin #118 – San Francisco ‘Decriminalizes’ Psychedelics

Psychedelic Bulletin #118 – San Francisco ‘Decriminalizes’ Psychedelics

Post published:September 12, 2022
Post category:Psychedelic Bulletin

Read more about the article Braxia Scientific Launches KetaMD in Florida; First Patients Complete Initial Virtual Ketamine Treatments At-Home

Braxia Scientific Launches KetaMD in Florida; First Patients Complete Initial Virtual Ketamine Treatments At-Home

Post published:September 12, 2022
Post category:Press Release

Read more about the article Braxia Scientific to Present at H.C. Wainwright 24th Annual Global Investment Conference September 12-14, 2022

Braxia Scientific to Present at H.C. Wainwright 24th Annual Global Investment Conference September 12-14, 2022

Post published:September 11, 2022
Post category:Press Release

Read more about the article Reunion Neuroscience Inc. to Participate in Upcoming Investor Conferences

Reunion Neuroscience Inc. to Participate in Upcoming Investor Conferences

Post published:September 9, 2022
Post category:Press Release

Read more about the article Algernon Pharmaceuticals Secures Lead Sponsorship of 2022 Wonderland Psychedelic Conference in Miami

Algernon Pharmaceuticals Secures Lead Sponsorship of 2022 Wonderland Psychedelic Conference in Miami

Post published:September 9, 2022
Post category:Press Release

Read more about the article Bexson Biomedical Announces Participation in the Jeffries Innovation in Mental Health Summit

Bexson Biomedical Announces Participation in the Jeffries Innovation in Mental Health Summit

Post published:September 9, 2022
Post category:Press Release

Read more about the article MindMed Announces Positive Results from Collaborators’ Placebo-Controlled Investigator-Initiated Trial Published in Peer-Reviewed Journal

MindMed Announces Positive Results from Collaborators’ Placebo-Controlled Investigator-Initiated Trial Published in Peer-Reviewed Journal

Post published:September 9, 2022
Post category:Press Release

Read more about the article Small Pharma to Participate in Upcoming September Investor Conferences

Small Pharma to Participate in Upcoming September Investor Conferences

Post published:September 8, 2022
Post category:Press Release

Read more about the article Optimi Health Completes Largest Legal Natural Psilocybin Harvest in Canadian History

Optimi Health Completes Largest Legal Natural Psilocybin Harvest in Canadian History

Post published:September 8, 2022
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.